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Abstract
Background: Most olfactory testings are subjective and since they depend upon the patients'
response, they are prone to false positive results. The aim of this study was to use quantitative brain
perfusion SPECT in order to detect possible areas of brain activation in response to odorant
stimulation in patients with post-traumatic impaired smell in comparison to a group of normal
subjects.
Methods: Fourteen patients with post-traumatic impaired smell and ten healthy controls were
entered in this prospective study. All subjects underwent brain SPECT after intravenous injection
of 740-MBq 99mTc-ECD and 48 hours later, the same procedure was repeated following olfactory
stimulus (vanilla powder).
Results: In most of seven regions of interest (Orbital Frontal Cortex, Inferior Frontal Pole,
Superior Frontal Pole, Posterior Superior Frontal Lobe, Parasagittal Area, Occipital Pole, and
Cerebellar area) the post-stimulation quantitative values show increased cortical perfusion being
more pronounced in normal volunteers than the anosmic patients (except cerebellar areas and the
right occipital pole). Maximal activation was observed in orbitofrontal regions (right+ 25.45% and
left +25.47%).
Conclusion: Brain SPECT is a valuable imaging technique in the assessment of post-traumatic
anosmia and could be competitive as an alternative to other imaging techniques, especially when
functional MRI is unavailable or unsuitable. However, this procedure may benefit from
complementary MRI or CT anatomical imaging.
Background
Although olfaction is the primal sense in animals, it has
also an important role in the human life. Loss of this
unique sensation could be extremely unpleasant and can
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be associated with deterioration of communicational
functions of patients [1,2]. In fact, disorders of the sense
of smell can be frustrating for both the patient and physi-
cian [3]. Quality of life studies have shown a general
decrease in the level of satisfaction with life among those
patients with continuing olfactory impairment[4]. Conse-
quently, there is a growing interest into the investigation
of smell disorders in both research and clinical practice
and lots of efforts is being made to provide a noninvasive
tool to elucidate the underlying pathology.
The ability to accurately measure loss of olfactory function
is important not only for research purposes, but also to
follow progression of the disease and for appropriate
management of patients. The most powerful tools the cli-
nician has in the diagnosis of olfactory disorders are only
the patient's history and clinical assessment [5]. However,
clinical definition and measurement of smell loss have
been difficult to achieve, in part because the symptom is
dependent upon patients' subjective complaints and in
part because techniques used to demonstrate smell loss
are based upon psychophysical measurements[6].
Most objective testings rely on measuring detection
thresholds of a specific odorant and/or by measuring the
ability to identify odorants by the patients[3,7]. Although
it has been noted that these tests are capable of estimating
various levels of decreased sense of smell and are also
somewhat able to identify malingerers, but all of these
methods have major limitations, which are widely
acknowledged [3]. One of the main problems that stand
in the way of analyzing olfactory disorders at present is
that the majorities of methods are largely subjective and
depend upon the patients' response. It is on this account
that many of tests that have been conducted in this field
do not carry much impact as they are not fit for quantifi-
cation of these disorders. There is a strong likelihood that
the patient is out to deceive the analyst by pretending
malingering; in the case of the existence or nonexistence
of post-traumatic impaired smell, which is a frequent
complication of head injury[8]. Olfactory dysfunction fol-
lowing trauma is currently compensable according to
existing American Medical Association guidelines and
therefore either from the legal point of view or for plan-
ning an appropriate medical management, differentiating
real impaired smell from affections of the patients is of
unique importance. Unfortunately, up to now all meth-
ods which have been devised for differentiating these two
groups have major limitations, not completely reliable
and in the case of electrical olfactory evoked potentials,
olfactometers or electroencephalograms were restricted to
research centers and are nonpractical for general use[3,9].
A review of the literature revealed that only one study has
evaluated the brain single photon emission tomography
(SPECT) findings in patients affected by post-traumatic
impaired smell[10] and information about the efficacy of
this technique is extremely scarce. The results of this only
study are partially confirmed in another study using posi-
tron emission tomography (PET). However, it was
emphasized that further works should be undertaken to
evaluate the role of SPECT and PET functional imagings as
screening tools for the evaluation of this disorder. Among
different and currently-available imaging techniques for
the study of the olfactory system, functional magnetic res-
onance imaging (fMRI) has been more encouraging and is
able to detect areas of brain activity in response to odorant
stimulation in more detail than older methods[3,11,12].
However, its use is still limited to research centers. There-
fore, we decided to use a similar rational by using SPECT
in order to detect possible areas of brain activity in
response to odorant stimulation and to evaluate the
potential of SPECT imaging to identify real cases of
impaired sense of smell by investigating the quantitative
SPECT findings in post-traumatic patients and in compar-
ison to a group of normal subjects.
Methods
From January 2004 to January 2005, twelve te fourteen
patients with impaired sense of smell (8 men and 6
women) and ten healthy control volunteers (6 men and 4
women), all right handed, were entered in this prospec-
tive study. Each participant was healthy, not taking any
medication, was able to breath normally in each naris,
and had no subjective nasal pathology. The cases were
selected from a population of patients referred to our
otolaryngology department for evaluation and treatment
of their post-traumatic impaired smell. Fourteen patients
accepted to participate in our study. All participants had a
history of mild to moderate head injuries followed by
post-traumatic impaired smell. The time interval between
the SPECT examination and the traumatic insult was 3 to
8 years (mean time interval, 4.6 years). None of patients
had history of olfactory diseases or invasive therapeutic
interventions on brain or nose before or after the trau-
matic insult. Control volunteers had also no history of
mental disorder or head trauma.
The diagnosis of smell impairment was based on prelimi-
nary and limited olfactory stimulation testing using Cain's
test, which revealed impairment in identifying common
odors in all subjects. The findings however, are limited
since this test is not adequate to fully evaluate the degree
and type of smell loss [13]. The presence of normal olfac-
tory perception in control group was also assessed by the
same method. All subjects were free of remarkable mental
disorders as assessed by a psychiatric interview at the time
of examination.BMC Nuclear Medicine 2005, 5:6 http://www.biomedcentral.com/1471-2385/5/6
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All patients gave informed consent to participate in this
study, which was approved by the committee on ethics at
the faculty of medicine, university of Tehran.
Brain scintigraphy
A commercial ECD preparation was used. The labeling
and quality control procedures were performed according
to the manufacturer's instructions. All subjects had an
intravenous line established while they were lying down,
with their eyes closed and ears unplugged, in a quiet dark-
ened room with low ambient sound and light. After
approximately 30 min, each subject received a 740-MBq
intravenous injection of tracer while they were still lying
down in the same quiet darkened room.
One hour after IV injection of 750 MBq (20 mCi) 99mTc-
ECD in a room with low level of ambient light and mini-
mal background noise, SPECT procedure was performed.
Scans were performed on a dual head ADAC camera,
equipped with a pair of low energy, high resolution colli-
mators. The full-width at half maximum (FWHM) of this
system, as measured in-house, was 12-mm for 99mTc.
Standard head positioning was based on uniform align-
ment of the external auditory meatus using automated
table positioning and camera-to-head-detector ratio val-
ues. The total acquisition time was 35 minutes for each
Study. Images were acquired in a 64 × 64 × 64 three-
dimensional pixel matrix at 64 steps, 30 s each step.
Before reconstruction of the images, attenuation correc-
tion of the images was carried out by the Chang method
(attenuation coefficient 0.12 cm-1). Then the data were
processed by back projection and filtered by Butterworth
filter, using a Nyquist frequency cutoff of 0.5 and order of
5. Images were reconstructed and displayed in all three
orthogonal planes.
48 hours later, the same procedure with all of the above-
mentioned steps was repeated while vanilla powder stim-
ulus was delivered in both nostrils. For olfactory stimula-
tion during normal breathing, vanilla powder stimulus
(10 minutes of saturated air in 2 seconds) was delivered in
both nostrils simultaneously by an electronic pump every
five inspirations, for a total 7 minutes. Such a long time
interval was chosen to avoid adaptation effects. Seven
minutes following the olfactory stimulus, 750 MBq (20
mCi)  99mTc-ECD was injected intravenously and subse-
quently, image acquisition was performed 60 minute post
injection.
The regions of interest at the sagittal cut used for the quantitative analysis Figure 1
The regions of interest at the sagittal cut used for the quantitative analysis: 1 = orbital frontal cortex, 2 = inferior frontal pole, 
3 = superior frontal pole, 4 = posterior superior frontal lobe, 5 = parasagittal region, 6 = occipital pole, 7 = cerebellar region.BMC Nuclear Medicine 2005, 5:6 http://www.biomedcentral.com/1471-2385/5/6
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Statistical evaluation
The method of SPECT image analysis was similar to that
of Varney and Bushnell[12]. Using a sagittal cut that
bisected the frontal lobes at approximately level of the
olfactory nerve at anterior end and level of the occipital
pole posteriorly. Seven regions of interest (ROI) were
drawn for quantitative analysis:
1. Orbital Frontal Cortex.
2. Inferior Frontal Pole.
3. Superior Frontal Pole.
4. Posterior Superior Frontal Lobe.
5. The Parasagittal Area.
6. The Occipital Pole.
7. The cerebellar area.
The mean activity in each of the seven ROIs in either hem-
isphere was calculated. Fourteen uptake indexes were
obtained for each person (Fig 1). We evaluate the post-
stimulation values of each segment as a fraction of the cor-
responding pre-stimulation values: [(post-stimulation
counts minus pre-stimulation counts)/prestimulation
counts] × 100.
Statistical analysis
Statistical analysis was performed using Variance Analysis
(ANOVA) and student's t-test for paired data and compar-
ison of demographic data. SPSS for windows (Release
11.5.0) was used for statistical analysis. A probability of
less than 0.05 was considered significant.
Results
The groups were comparable in regard to demographic
data [mean age 37 (18–56) yr in the anosmic Vs 33 (22–
42) yr in the normal control group].
Quantitative SPECT data for each region of anosmic and
control subjects are shown in table 1. In most of the
regions the mean post-stimulation values, which are
expressed as the percentage of the pre-stimulation values,
are significantly higher in the normal controls than the
anosmic patients (P < 0.05) (Fig. 2). However, in both
sides of cerebellum and in the right occipital region no
statistically significant increase in the post-stimulation
values is noted (P = 0.05). No statistically significant dif-
ference in the pattern of cerebral activation was identified
regarding the patient's gender or right versus left hemi-
spheric activity (P > 0.05).
Discussion
Availability of an objective and noninvasive technique by
which smell function can be readily demonstrated and
quantitated is of significant medical and medicolegal
importance. Efforts to establish objective techniques to
measure hyposmia and to determine the existence or non-
existence of post-traumatic impaired smell have included
EEG, olfactory evoked responses, and magnetoencepha-
lography, but they were without particular success [6].
With the use of brain CT and MRI, some details of CNS
pathology were obtained and measurements of olfactory
bulb size and other anatomical structures in the CNS
olfactory system have become possible in normal subjects
and in patients with hyposmias and impaired smell of var-
ious causes14. However, these methods provided no infor-
mation about functional olfactory performance [6,15]. In
fact, up to now, the main available method for obtaining
functional information about the olfactory system is func-
Table 1: (Mean ± SD) Percentage Increases of Brain Perfusion in All Selected ROIs in Normal and patients Subjects
ROI Patients with smell 
impairment
controls P value
Orbitofrontal Right 7.2 ± 38.46 25.45 ± 44.45 0.03
Left 8.16 ± 38.60 25.47 ± 44.48 0.03
Inferofrontal Right 9.14 ± 36.27 25.07 ± 46.02 0.04
Left 8.22 ± 38.39 24.09 ± 45.81 0.03
superofrontal Right 9.32 ± 39.91 24.06 ± 42.98 0.04
Left 7.99 ± 40.34 21.30 ± 39.64 0.03
Posterosuperofrontal Right 8.32 ± 40.38 20.70 ± 39.20 0.04
Left 8.10 ± 38.57 20.41 ± 40.79 0.04
Parasagital Right 6.68 ± 36.08 20.59 ± 43.49 0.03
Left 6.24 ± 36.02 18.57 ± 40.46 0.04
Occipital Right 7.42 ± 37.53 22.87 ± 41.58 0.05
Left 6.74 ± 35.95 23.27 ± 44.61 0.04
Cerebellum Right 4.34 ± 32.74 22.06 ± 44.02 0.05
Left 5.57 ± 33.80 23.19 ± 42.62 0.05BMC Nuclear Medicine 2005, 5:6 http://www.biomedcentral.com/1471-2385/5/6
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tional MRI (fMRI). Since its introduction, functional MRI
(fMRI) showed promise in defining brain activation in
response to visual, auditory, and somatosensory stimuli.
This technique has been applied to normal and anosmic
subjects using olfactory stimuli to obtain quantitative data
[6]. Although only limited functional imaging studies are
available, fortunately these efforts have been promising
and successful results are reported. In a recent study by
Henkin and Levy [12] evaluated the role of fMRI to define
brain activation in response to olfactory stimulation in
patients who never recognized odors (congenital hypos-
mia). Brain activation in response to odors was present in
patients with congenital hyposmia, but the activation was
significantly lower than in normal subjects and patients
with acquired hyposmia. One of the most widely refer-
enced studies is that of Levy et al[6], in which the authors
found that brain activation to three different olfactory
stimuli (pyridine, menthone, amyl acetate) was lower in
all nine brain sections in anosmic patients compared with
normal subjects. This difference reached statistical signifi-
cance for mean activation for each odor in six of the nine
individual sections studied. In patients activation was
found in regions associated with CNS processing of olfac-
tory stimuli in normal subjects, but this activation was
much less, particularly in inferior frontal and cingulate
gyral regions of frontal cortex and in regions of medial
and posterior temporal cortex. The authors concluded
that quantitative CNS changes in response to olfactory
stimuli in patients with hyposmia, demonstrate a novel,
objective method by which these patients can be identi-
fied. In another study done by Levy et al[11], fMRI was
obtained in 21 patients with Type I and II hyposmias.
Patients with Type I hyposmia (who could detect but not
recognize odors) had less activation than patients with
Type II hyposmia (who could detect and recognize odors,
albeit with less than normal acuity). Both patient groups
had less activation than normal volunteers. The authors
described fMRI as a simple, rapid technique that can be
used in a practical clinical setting to identify patients with
hyposmia and to differentiate patients with different types
of olfactory loss. However, it should be noted that fMRI
has some important drawbacks, which prompt us to use
quantitative brain perfusion SPECT as another objective,
noninvasive technique. In most places fMRI is more
expensive and has more contraindications and scheduling
difficulties.
Nuclear medicine procedures (SPECT and PET) has been
considered as functional imaging modalities by which
patients with smell loss can be identified, their abnormal-
ities quantitated and compared with findings in normal
subjects. In the study of Varney and Bushnell, neu-
roSPECT findings in patients rendered totally anosmic
from head injury were investigated. The authors under-
score the importance of orbital frontal hypoperfusion as a
paraclinical sign of post-traumatic impaired smell, partic-
ularly in patients with mild head injury who have normal
computed tomography and magnetic resonance imaging
scans [10]. In the study of Varney et al [16] eleven patients
with head injury resulting in severe impaired smell and 11
controls matched for age were investigated using quanti-
tative positron emission tomography. The study showed
that posttraumatic impaired smell is closely associated
with cerebral perfusion abnormalities evident in cerebral
PET images.
As to our knowledge, there is only a single similar study to
determine impaired olfactory function following odorant
stimulation evaluating the potential of SPECT imag-
ing[17]. In the study of Di Nardo et al, 15 volunteers
(including 10 healthy adults and 5 patients with post-
traumatic impaired smell) underwent brain SPECT by
m99Tc-HMPAO, before and after olfactory stimulation
with lavender water. As to our results, variable degrees of
cortical activation were detected. Gyrus rectus (+24.5%),
orbito-frontal cortex (right +26.6%, left +25.6%), and
superior temporal (right +9.9%, left +5.5%) cortical areas
were remarkably activated, while only a slight increased
perfusion was present in middle temporal (right +3.2%,
left +2.1%) and parieto-occipital (right +0.4%, left +2%)
regions. Those patients affected by posttraumatic
impaired smell showed markedly less perfusion incre-
ment as low as 0.5% in every olfactory area. Similarly, our
Pre-stimulation (upper rows) and Post-stimulation (lower  rows) SPECT images of a volunteer control Figure 2
Pre-stimulation (upper rows) and Post-stimulation (lower 
rows) SPECT images of a volunteer control.BMC Nuclear Medicine 2005, 5:6 http://www.biomedcentral.com/1471-2385/5/6
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results demonstrate that patients with impaired smell
exhibit decreased brain activation compared with normal
subjects following olfactory stimulation. These results
might be expected based upon patient complaints of lack
of smell[6], but they have not been widely documented by
objective criteria. It has been shown that all regions of cer-
ebral cortex have blood flow increment after pure first
nerve (CN1) stimulation. This technique allows identifi-
cation and definition of olfactory areas, and makes it
potentially of value to the clinicians. Although the find-
ings of Di Namdo wee are confirmed by our larger series
of patients, however few minor differences between two
studies are present. In our study more activation in the
parietal and occipital regions was observed, that could be
explained by the different radiotracer (HMPAO vs. ECD)
used in our study. In fact this difference could be presum-
ably due to differences in pharmacokinetics of these two
radiopharmaceuticals. As it was previously reported by
Patterson et al, radiotracer activity of the parietal, occipital
and superior temporal cortices were significantly lower
with 99mTc-HMPAO than 99mTc-ECD[18]. Although both
tracers have good results in depicting the cerebral blood
flow (rCBF), as it was previously shown by Pupi et al[19],
99mTc-ECD uptake is significantly more linear with regard
to rCBF and thus it has less back-diffusion and better cor-
relation with blood flow.
Depending on the method of analysis (fMRI, PET or
SPECT), nature, intensity of the stimulant or previous
exposure of the subjects to the odorant, different patterns
of cerebral activation are observed [17,20]. It seems that
orbital and frontal regions are almost always activated.
Behavioral evidence and imaging findings (PET and fMRI)
have suggested that laterally specialized mechanisms for
odor processing exist and that the right orbitofrontal
region has a main role in the olfaction process [21,22].
However, the results of our study and that of the Di Nardo
et al using SPECT did not show any statistically significant
perfusion lateralization within the olfactory areas, which
could be interpreted by the differences in methods of
analysis[17,20].
Although it was previously found that women outperform
men during odor identification [23, 24, 25), but our study
has shown that the male and female have similar pattern
of cerebral activation with no significant difference with
respect to the extent and amount of the activated regions.
Further investigation concerning the issue of gender
effects on olfactory function seems warranted.
Similar to the fMRI technique, brain perfusion SPECT
offers an objective approach, by which smell function can
be assessed quantitatively without significant patient par-
ticipation. Similarly, this technique offers another objec-
tive method by which differences between groups can be
easily quantitated. However, SPECT procedure takes
much more time in comparison to fMRI and involves
radiation, and tends to be more expensive in many parts
of the world. SPECT may be better than fMRI to visualize
certain parts of the brain (such as the orbitofrontal cortex)
that may be harder to see by fMRI due to signal distortions
near the skull base. In comparison to SPECT, fMRI is
faster, generally cheaper, can be repeated with different
stimuli, and may be performed at the same time as con-
ventional MRI to provide detailed anatomical images.
Finally it should be emphasized that our study is not free
of drawbacks. There are some areas of brain unrelated to
olfaction that appear to show activation. This remains
unexplained and raises questions about the specificity of
the SPECT images for olfaction. To answer this questions,
experiments should be performed namely with no odor
stimulation, with control of other process of olfactory
stimuli such as memory, emotion or physiological blood
pressure changes, etc. Additional conventional imaging
such as MRI or CT would be useful to show the degree of
brain encephalomalacia or atrophy. These regions would
not be expected to activate, and may create falsely
decreased activation in SPECT studies. In some cases of
brain injury, despite minimal brain MRI changes, the
apparently normal brain tissue may be functionally
abnormal on SPECT. This distinction should be made in
future studies when interpreting the SPECT images, since
in regions of decreased SPECT activity, the corresponding
degree of atrophy or encephalomalacia is not evident
without the anatomical imaging. Also it should be noted
that the Coin's test is not sufficient and completely relia-
ble for confirming the presence of smell impairment and
therefore further studies comparing brain perfusion
SPECT with fMRI (as another reliable method in the
assessment of smell impairment[26,27]) is warranted.
Conclusion
Our study demonstrates that brain SPECT is a valuable
imaging technique and could be considered as an alterna-
tive to other imaging modalities (particularly fMRI) in the
diagnostic management of patients complaining of post-
traumatic impaired smell. SPECT is specially a useful
alternative when fMRI is unavailable or unsuitable and it
is beneficial when more accuracy is desired (when fMRI
results are either inconclusive or conflict with other clini-
cal data). However, brain SPECT may benefit from com-
plementary MRI or CT anatomical imaging.
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